Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
PMID 22221769
Comparison Table (Structure, Pathway, Research Classification) Each compounds classification reflects its underlying mechanism rather than a shared fat-loss peptide category: AOD-9604 remains research-stage and inconclusive, GLP-1 S has the most extensive clinical backing of the three, and tesamorelin occupies a narrower but well-documented niche in visceral fat and GH-axis research
Store the lyophilized vial at -20C (stable 24+ months)
Standard titration moves from 2.5mg to 5mg, then to 7.5mg, 10mg, 12.5mg, and finally 15mg, with each step lasting at least four weeks
As with any medical treatment, potential risks and benefits should be considered before starting peptide therapy
US$ 21.00
US$ 25.55
US$ 23.98
US$ 21.05
US$ 22.20
